bf/NASDAQ:CMPS_icon.jpeg

NASDAQ:CMPS

COMPASS Pathways plc

  • Stock

USD

Last Close

5.59

06/11 22:29

Market Cap

451.06M

Beta: 2.51

Volume Today

708.59K

Avg: 279.39K

PE Ratio

−4.64

PFCF: −5.88

OverviewFinancialsAPI

    Description

    COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as C...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-03-302019-12-312021-05-132023-02-282024-05-082025-05-06

    Revenue (Estimate*)

    1M2M3M4M2019-03-302019-12-312021-05-132023-02-282024-05-082025-05-06

    *Estimate based on analyst consensus